chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pressure in his brain steam causes constant pain; light sensitivity; he cannot walk; pressure in his brain steam causes constant pain; ill; never was able to even start his senior year or finish school; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a 17-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced headache (Verbatim: pressure in his brain steam causes constant pain), photophobia (Verbatim: light sensitivity), unable to walk (Verbatim: he cannot walk), head pressure (Verbatim: pressure in his brain steam causes constant pain), unwell (Verbatim: ill) and activities of daily living impaired (Verbatim: never was able to even start his senior year or finish school). The outcome of the headache, photophobia, unable to walk, head pressure, unwell and activities of daily living impaired were not reported.   The reporter considered the headache, photophobia, unable to walk, head pressure, unwell and activities of daily living impaired to be possibly related to Bexsero and Bexsero Pre-Filled Syringe Device.   The company considered the headache, photophobia, unable to walk, head pressure, unwell and activities of daily living impaired to be possibly related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-JUL-2023 This case was reported by a patient's relative via interactive digital media. The patient receive this at age 17 before he was to start his senior year.  The patient became so ill he was now about to turn 21 and never was able to even start his senior year or finish school.  Some days he could not walk.  The pressure in his brain steam caused constant pain and he was so light sensitive he had to stay in his house with lights off during the day.  This and all vaccines had risks (and so did meningitis) but the vaccine was not a safe way to protect your child.  The reporter thought the event might had been related to product/device.
Fever of 101.1; headache; extreme fatigue; muscle pain; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1685), intramuscular on 07Jan2021 14:00 at single dose at left arm for covid-19 immunization. Medical history was none, no known allergies. Concomitant medications in two weeks included venlafaxine, levothyroxine sodium (SYNTHROID). Patient didn't receive any other vaccines in 4 weeks. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient had not been tested for COVID-19. The patient experienced fever of 101.1, headache, extreme fatigue, muscle pain on 08Jan2021 with outcome of recovered on 10Jan2021. These symptoms subsided after 2 days. Patient didn't receive treatment for events. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care.
Chest pain, rash on arms and trunk,  facial swelling, tongue swelling, diaphoresis
Headache, Myalgia, fatigue. insominia  Narrative:  employee reported headache 02/04/21 until 02/07/21, muscle pain  02/04/21, fatigue 02/05/21, insomnia 02/04/21 until 02/06/21, resulted in  unable to work 02/06/21 anddid not seek medical attention for the symptoms  Other Relevant History:
itching in the shot are; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PRURITUS (itching in the shot are) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itching in the shot are). At the time of the report, VACCINATION SITE PRURITUS (itching in the shot are) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.     No treatment medications were reported.
sinisistus; low grade fever; cough; body aches; chills; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sponsored program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiry date: not reported), via an unspecified route of administration on 06Apr2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced sinisistus, low grade fever, cough, body aches and chills. Patient and her husband were due for second dose of bnt162b2 vaccine Thursday, she had two questions, what was the reason for the time laps in reactions (14-15 days) and should they get the second dose. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Extensive local swelling including entire arm and proximal forearm with localized pain and urticaria.
type 1 diabetes mellitus p/3 doses of vax;tx for DKA;Annual follow-up states the child has not recovered.
Significant injection site pain. Fever and chills began approximately 12am 11/9/2021. Loss of appetite associated with fever and loss of energy.
Low fever set in about 14 hours after vaccine, along with chills and fatigue.  Slept a lot for about 48 hours.  Nausea and decreased appetite, dry heaving and minor vomiting.  Nausea persisted for about 4 days after vaccine.  Mild headache as well. Treatment was just rest and easily digestible foods. Recovering slowly.
the first and third doses were not painful and the second dose was painful; This spontaneous report was received from a female patient of unknown age who was reporting on herself. The patient's pertinent medical history, concomitant therapies, drug reactions and allergies were not reported.  On an unknown date in January 2019 (reported as end of January 2019), the patient received second dose of 3-dose vaccination regiment with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot #, expiry date, route of administration and anatomical location were not provided) for human papilloma virus prevention. She stated that this dose was painful and added that neither first nor third dose were painful. She did not seek medical attention and no treatment was given. On an unknown date in 2019, the patient recovered from this condition.  Causality assessment was not provided.
4/7/08 - Painful, became swollen, redness, bump day of administration (tired and itching).  For next 3 days - headache, extreme fatigue, stomach boiling, fever (101), injection site very swollen, itchy, red, and hot to the touch (about soft ball size).  One week later - area golf ball size.  Lump under skin.  Still painful and itchy - HA, fever, fatigue gone.  Still has lump.  Some pain & itching.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed chickenpox, consisting of approximately 100 pustules on his chest and scattered on the rest of his body. Pt was febrile 105F. Pt was treated with Benadryl and acetaminophen was initiated.
At booster dose appt, pt reported that after first dose pt experienced jaw numbness for 15 min. Resolved on it's own. No reaction with 2nd Pfizer vaccine.
Vomiting lasting 1 day, diarrhea lasting about 1 week and fever lasting 1 day.
NO REACTION. MODERNA VACCINE EXPIRED ON 10-29-2022. VACCINE WAS GIVEN ON 11-01-2022.
Upon leaving the site my husband had great difficulty walking. Upon arrival home he seemed unusually confused and over the course of the next 15 hrs had bouts of incontinence. He was up 6 times during the night (usually only 1-2x) and unable to get himself out of bed without assistance. Walking continued to be very unsteady. I thought perhaps he had a mini-stroke. I relayed this to his PCP but he didn't think it was vaccine related
Client received the 1st dose of Pfizer COVID vaccine lot #EW0171 and expiration date 4/24/21 at around 4pm. Client reported to vaccinator that she couldn't see for a few seconds right after injection.  Vaccinator walked client over to observation area where PHN  arrived to find client sitting upright alert and oriented  x4 in a chair. Client reports she had blurred vision right after injection. At 4:03pm vitals were taken: blood pressure: 133/93, pulse: 88 and oxygen: 98%.  Client reports blurred vision is completely resolved.  Client has no medical history and only takes vitamins. Client did report she gets headaches and has been seen by doctors for them. Client reports she has been very stressed lately and has been running around all day.  At 4:10PM vitals were taken: blood pressure: 134/93, pulse: 88 and oxygen: 98%. Client reports she has not eaten since 9 or 10 am. PHN offered water.  At 4:15PM vitals were taken: blood pressure: 142/87, pulse:79 and oxygen: 98%.  At 4:25PM vitals were taken: blood pressure: 126/89, pulse:78 and oxygen: 98%. PHN advised client to speak to her provider about her blurred vision and ER precautions. At 4:33pm client left facility with a steady gait.
Clinic provider claims they have seen adverse events from FLUZONE HIGH DOSE vaccine given at other facilities.
Temp 104.5 evening of shot, T 102 following day. Seen in office by MD
Information has been received from a registered nurse, referring to a female patient (also a nurse) of unknown age who was not pregnant. The patient's medical history, concurrent condition and concomitant therapy were not reported. On an unknown date, the patient was administered a dose of ZOSTAVAX (lot #, expiration date, dose and route were unknown). On an unknown date after receiving the vaccine, the patient developed a rash. The outcome of rash was unknown. The causality assessment between the rash and ZOSTAVAX was not reported. Additional information has been requested.
Patient received 2nd dose of Moderna COVID-19 vaccine under EUA on 4/6/2021 and tested positive for COVID-19 via nasal swab 5/5/2021.
Crying since recieving imms.  Warm to touch @ admin. site.  No pn or redness @ imm site.
-Muscle pain in right arm on 8/20 & 8/21 -Headache on 8/21 -Right armpit pain began Thursday 8/26 PM, gone 9/1 -Redness at injection site began 8/28 -Redness extended beyond injection site through upper arm on 8/29, gone 9/1
Information has been received from a nurse who consulted a pharmacist concerning an adult patient who was vaccinated IM inadvertently into the abdomen with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. It was reported that the patient had a reaction but the reporter did not have the details of the reaction. The patient was being monitored by the nurses. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 25-JUL-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K005957, expiration date 08-MAR-2015, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 1056 hours with lowest recorded temperature of 20 Fahrenheit degree. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
After leaving the store, first sign of adverse reaction was a weakness in lower left leg/foot. Did not feel like it would support me; followed by numb feeling on left side in face, tongue, teeth and left arm, with metallic taste in mouth. Did not experience slurring or drooping musculature, so sat and waited a bit with my husband to see if it would pass. After about 10 minutes, normalcy returned, but I felt very tired and went home and slept 5 hours. I believe this was an allergic reaction. I have always obtained an annual flu shot with no adverse reaction. Therefore, I am wondering what precautions, if any to take next year and in future.
Injection site was very tender/ injection site hurt/had pain at the injection site; Had swelling at the injection site; Injection site had a bump/bump, it was itchy and hard, and this morning it is a little bigger/feel a bump in the skin/itches but not so much, and they feel a bump in the skin.; Injection site was hard/injection site was bump and  hard; Injection site was a little red/m injection site had redness; Injection site was itchy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site was itchy), VACCINATION SITE PAIN (Injection site was very tender/ injection site hurt/had pain at the injection site), VACCINATION SITE INDURATION (Injection site was hard/injection site was bump and  hard), VACCINATION SITE ERYTHEMA (Injection site was a little red/m injection site had redness) and VACCINATION SITE SWELLING (Had swelling at the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hysterectomy. Concurrent medical conditions included Drug allergy (Allergic to several antibiotics).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Oct-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site was itchy), VACCINATION SITE INDURATION (Injection site was hard/injection site was bump and  hard) and VACCINATION SITE ERYTHEMA (Injection site was a little red/m injection site had redness). On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site was very tender/ injection site hurt/had pain at the injection site), VACCINATION SITE SWELLING (Had swelling at the injection site) and VACCINATION SITE RASH (Injection site had a bump/bump, it was itchy and hard, and this morning it is a little bigger/feel a bump in the skin/itches but not so much, and they feel a bump in the skin.). At the time of the report, VACCINATION SITE PRURITUS (Injection site was itchy), VACCINATION SITE PAIN (Injection site was very tender/ injection site hurt/had pain at the injection site), VACCINATION SITE INDURATION (Injection site was hard/injection site was bump and  hard), VACCINATION SITE ERYTHEMA (Injection site was a little red/m injection site had redness), VACCINATION SITE SWELLING (Had swelling at the injection site) and VACCINATION SITE RASH (Injection site had a bump/bump, it was itchy and hard, and this morning it is a little bigger/feel a bump in the skin/itches but not so much, and they feel a bump in the skin.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Second dose: had a fall 02Aug2021 and fell on right hand side and had to get an operation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Apr2021 (Lot number: ER8731) at the age of 65 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "penicillin allergy" (unspecified if ongoing), notes: Reaction: Hives. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose, lot: EP6955, NDC: Unknown , Expiration: Unknown , Route of administration: left arm, Time: First dose: AM), administration date: 20Mar2021, when the patient was 65 years old, for Covid-19 immunization.  The following information was reported: FALL (non-serious) with onset 02Aug2021, outcome "unknown", described as "Second dose: had a fall 02Aug2021 and fell on right hand side and had to get an operation".  Additional information: It was reported Second dose: Patient had a fall 02Aug2021 and fell on right hand side and had to get an operation: The caller states she received the vaccines in the left arm because the caller had a fall on 02Aug2021 and fell on right hand side and had to get an operation on right shoulder. The caller clarifies the fall occurred on 02Aug2021.   No follow-up attempts are possible. No further information is expected.
Swelling around collarbone area and under left arm; Dose:1 and Dose:2 Moderna, Dose:3 Pfizer; Dose:1 and Dose:2 Moderna, Dose:3 Pfizer; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Jan2022 09:00 (Lot number: Fl3197) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: CITALOPRAM. Vaccination history included: Moderna (Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Right), administration date: 08Apr2021, when the patient was 65 years old, for COVID-19 Immunization; Moderna (Dose Number: 1, Batch/Lot No: 001B21A, Location of injection: Arm Right), administration date: 11Mar2021, when the patient was 65 years old, for COVID-19 Immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 11Jan2022 09:00, outcome "unknown" and all described as "Dose:1 and Dose:2 Moderna, Dose:3 Pfizer"; SWELLING (non-serious) with onset 13Jan2022 12:00, outcome "not recovered", described as "Swelling around collarbone area and under left arm". The event "swelling around collarbone area and under left arm" was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of swelling.  Additional information: Other vaccine in four weeks was reported as no. Patient was not covid prior vaccination and did not test for covid post vaccination.   No follow-up attempts are possible. No further information is expected.
I had a booster yesterday Pfizer booster; I had a booster yesterday Pfizer booster and my under armpit is like painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 23Dec2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer unknown), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 23Dec2021, outcome "unknown", described as "I had a booster yesterday Pfizer booster"; AXILLARY PAIN (non-serious) with onset Dec2021, outcome "unknown", described as "I had a booster yesterday Pfizer booster and my under armpit is like painful".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling of the lymph nodes in the shoulder/neck, above the collarbone on the left side Noticed bumps and had telehealth appointment with doctor Scheduled blood test and ultrasound of the neck Blood test normal; doctor identified swollen lymph nodes from ultrasound No further action taken; area monitored for less swelling/worsening swelling
Body aches started around 11pm on Sunday.  Nausea the next morning at 5am.  fever continued all day Monday topped out at 100.8.  was lethargic, with body aches, headache and nauseas all day Monday.  Started to feel better around 8pm Monday.
Following the first COVID vaccine dose on Dec/18/2020, I had headaches that started on the third day and ended on the tenth day.  The headaches were usually light, unilateral, and alternating from one side to the other. I was usually functional except on the fourth and seventh days where the headaches were moderate to severe, and I took naps to help with the headaches for those two days. I have never had an issue with headaches before, and these symptoms were a new experience for me. I did not take any medications as treatment for the headaches. Following the second COVID vaccine dose on January/7/2021, I felt fatigue and generalized muscle aches within six to twelve hours, and these symptoms lasted for two days. On January/10/2021, when I woke up that morning I again felt light, unilateral, and alternating headaches. In addition, I noticed that I was unable to move the left side of my face. I felt moderate tingling sensations associated with the distribution of the paralysis. When I looked in the mirror, I could quite noticeably see asymmetry in my face. I immediately went to the emergency department at the hospital where my primary care doctor is located. I was kept in the hospital into the next day for observation. After evaluation by a neurology team and an MRI, I was provided with the diagnosis of Bells Palsy. I have never previously been diagnosed with Bells Palsy, and I have never previously had a hospital stay before. The doctors prescribed medications which I am currently taking. As of today January/12/2021, the symptoms have had some improvement, but the symptoms still continue.
Patient received 0.5 ml dose of MMR. Dr notified immediately when realized MMR given in error. Dr. notified mother, and discussed incident with her, as well as answered questions for mother. Manufacturer (Merck) notified.
This is a 70-year-old male with PMH of DM and HTN presents to the ED for evaluation of shortness of breath. Patient reports that he had COVID-19 symptoms for approximately 2 weeks ago and was tested positive for COVID-19 last week. Patient reports he still feels short of breath on exertion, mild loss of taste and smell, weakness and fatigue. Patient reports he was vaccinated with the J&J in June 2021. Patient reports he is more concerned now because he has persisted short of breath and not getting any better. In the ED, patient was given 6 mg of Decadron IV. Patient is currently saturating 97 98% on room air and appears mild short of breath on exertion. CTA shows extensive bilateral pulmonary infiltrates Patient denies any chest pain, dizziness, lightheadedness, palpitations, nausea, vomiting, diarrhea, fever and chills.
4:00 am I'd gotten up with the baby, and I got very hot and dizzy, and I passed out. My blood pressure was very low. My mother-in-law who was with me at the time came to my aid. She called paramedics. I went to ER; bloodwork there. They did bloodwork and noticed my potassium was dangerously low. They did an EKG, that came back normal. They waited on labs and gave me Potassium at ER and sent me home with a prescription for a Potassium supplement.  As soon as I started taking potassium about a week after being on the pills, I began to feel better (felt very weak up until then). Follow up next with doctor.